Is AI Better for Patients?

Why It Matters

If Optum’s integrated, AI‑driven approach succeeds at scale it could accelerate a shift to value‑based care and materially cut costs and hospital use, but concentrating risk and decisioning in one firm raises oversight and patient‑protection implications that policymakers must address.

Summary

Patrick Conway, CEO of Optum, described how his company is scaling value‑based care across its integrated platform—combining payer, provider, pharmacy and analytics—to reduce hospitalizations, lower total cost of care and boost patient experience. Optum is rapidly operationalizing hundreds of AI use cases, backed by at least $1.5 billion in UnitedHealth Group investment, to automate administrative tasks, speed prior authorizations to seconds and adjudicate claims in real time. Conway argued that predictable incentives, shared data and front‑line clinical innovation enable rapid migration from fee‑for‑service to two‑sided risk models, with many populations already showing improved outcomes and high Net Promoter Scores. He acknowledged the central tension of a single company bearing financial risk while building the AI that determines care decisions, stressing the need for scale, technology and public‑private collaboration to expand value‑based models nationwide.

Original Description

Is AI Better for patients? What is changing on the ground? Chip talks with Dr. Patrick Conway, Chief Executive Officer of Optum, a health services and technology business under parent company, UnitedHealth Group. They discuss how to ensure the health care industry’s use of AI serves patients first, particularly when the same company bears financial risk and builds the AI that decides who gets care. They also discuss whether use of AI can make value-based care the dominant payment framework, after two decades of policymaker support for the model.